Floorplan of the Global Village
AORTIC (African Organisation for Research and Training in Cancer) is a Pan-African non-profit organisation focusing on cancer in Africa. Our key objectives are to further research on cancers prevalent in Africa, facilitate and support training initiatives in oncology for health care workers, create cancer prevention and control programmes, and raise public awareness of cancer on the continent.
AORTIC strives to unite the African continent in achieving its goal of a cancer free Africa, and seeks to make a positive impact throughout the region though collaboration with health ministries and global cancer organisations.
Stands 3, 4, 5 & 6 (Stands shared with La Ligue contre le Cancer)
ALIAM promotes and develops the fight against cancer in all its aspect by encouraging North - South and South exchanges between leagues.
Public information, health professionals training and patient's assistance.
Stands 26 & 27
The American Cancer Society is the nationwide community-based voluntary health organization dedicated to eliminating cancer as a major health problem. The American Cancer Society saves lives by helping people stay well, helping people get well, by finding cures, and by fighting back. With more than two million volunteers nationwide, the American Cancer Society is one of the oldest and largest voluntary health agencies in the United States. The American Cancer Society, Inc. consists of a National Home Office with 13 chartered Divisions throughout the United States and a presence in most communities. More than 3,400 local offices nationwide are organized to deliver cancer prevention, early detection, and patient services programs at the community level. Community programs and services include the Relay For Life program. The American Cancer Society became a full UICC member in 1966.
Stand 35 & 36
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization for physicians and oncology professionals caring for people with cancer. ASCO is the only organization that encompasses all oncology subspecialties, allowing our members to grow from the professional and personal expertise of their colleagues worldwide and across disciplines. Join ASCO while at the meeting and receive a free engraved gift and immediate access to valuable member benefits. Current members stop by to receive your collectible ASCO pin!
Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees. The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects through, for example, the initiative “Making More Health” while also caring for employees. Respect, equal opportunity and reconciling career and family form the foundation of mutual cooperation. The company also focuses on environmental protection and sustainability in everything it does. In 2015, Boehringer Ingelheim achieved net sales of about 14.8 billion euros. R&D expenditure corresponds to 20.3 per cent of net sales. For more information please visit www.boehringer-ingelheim.com
The Canadian Partnership Against Cancer works with Canada’s cancer community to reduce the burden of cancer through co-ordinated system-level change. Grounded in and informed by the experiences of those most affected by cancer, the organization plays a unique role working with partners to support multi-jurisdictional uptake of the knowledge emerging from cancer research and best practices in order to optimize cancer control planning and drive improvements in quality of practice across the country. Partners include provincial and territorial cancer programs; federal organizations and agencies; First Nations, Inuit and Métis organizations; national health and patient organizations; and individual experts who provide strategic cancer control insight and advice from both patient and professional perspectives. Through sustained effort and a focus on the full cancer continuum from prevention and treatment through to survivorship and end-of-life care, the Partnership supports the collective work of the broader cancer control community in achieving long-term outcomes that will have a direct impact on the health of Canadians: reduced incidence of cancer, less likelihood of Canadians dying from cancer, and an enhanced quality of life of those affected by cancer. For more information, visit partnershipagainstcancer.ca. The Partnership is also the driving force behind cancerview.ca, which connects Canadians to cancer control services, information and resources. The Partnership is funded by Health Canada.
Stands 18, 19, 20 & 21
Cancer Research UK is the world’s largest independent funder of cancer research. Its vision is to bring forward the day when all cancers are cured. Since 1902 CRUK has found new ways to prevent, diagnose and treat cancer. CRUK-funded scientists’ pioneered early radiotherapy, developed some of the world’s top cancer drugs and discovered the tumour suppressor gene, p53. Its work has saved millions of lives across the world.
CRUK invests $500m annually in world-leading research across all 200 different types of cancer, working with partners in Europe, North America and Asia to accelerate research progress. It provides information to those affected by cancer, works to increase cancer awareness, and uses its powerful, independent voice to keep cancer at the top of the political agenda. CRUK funds some of the world’s leading experts in tobacco research and is a key player in international tobacco control. It became a full UICC member in 1986.
Cancon is a joint action to improve cancer control in Europe.
Cancon (officially European Guide on Quality Improvement in Comprehensive Cancer Control or CanCon; Cancon for short) is a joint action initiative, co-funded by participating organisations, institutes, universities and health care units, and the European Union. The total budget is 6 million euros.
Cancon started in 2014 and will continue until 2017. Cancon is producing a Guide for improving the quality of comprehensive cancer control. Hundreds of cancer experts are working on this.
Cancon will help Member States to place cancer firmly on their national public health agendas and improve national situations by applying and adapting recommendations in the Guide.
Chinese Anti-Cancer Association (CACA) is a non-government and non-profit organization in the field of oncology in China. Founded in 1984 and the headquarter office located in Tianjin, China. There are 44 professional societies, 46 full membership organizations, 30 local anti-cancer associations distribute in almost all provinces exceeding with over 47,000 members. The Seventh board member of CACA is composed of 199 members, including 65 executive members.
Through its 24 Member Societies - representing over 80 000 professionals - ECCO is the only multidisciplinary organisation that connects and responds to all stakeholders in oncology Europe-wide.
ECCO is a not-for-profit federation that exists to uphold the right of all European cancer patients to the best possible treatment and care, promoting interaction between all organisations involved in cancer at European level.
It does this by creating awareness of patients’ needs and wishes, encouraging progressive thinking in cancer policy, training and education and promoting European cancer research, prevention, diagnosis, treatment and care through the organisation of international multidisciplinary meetings.
The European Organisation for the Research and Treatment of Cancer (EORTC) unites European cancer clinical research experts to define better treatments for cancer patients.
Both multinational and multidisciplinary, the EORTC Network comprises more than 2,500 collaborators involved in cancer treatment and research in more than 300 hospitals in over 30 countries.
Through translational and clinical research, the EORTC offers an integrated approach to therapeutic strategies, drug evaluation programs, survivorship issues, and quality of life.
EORTC Headquarters, a unique pan European clinical research infrastructure, is based in Brussels, Belgium, from where its various activities are coordinated and run.
Stands 63 & 64
The Fédération Française de Tennis (FFT) ("French Tennis Federation" in English) is the governing body for tennis in France. It was founded in 1920, and is tasked with the organisation, co-ordination and promotion of the sport. It is recognised by the International Tennis Federation and by the French Minister for Sports. Its headquarters are at the Roland Garros stadium.
The FFT will present the "Tennis - Sport, Health and Well-being" project to be launched in 2017.
The Brazilian Federation of Philanthropic Institutions in Support of Breast Health (FEMAMA) is a non-profit, civil association, which operates through 58 partnering NGOs in 18 different Brazilian states.
FEMAMA has, as its mission, to influence the formulation of a national public policy in health care and related fields to generate the guarantee of universality, integrity, and equity in the attention to breast health, in the context of the full health and rights of Brazilian women. For that, the entity supports the development of the capacity of political action of organizations, articulating them with a shared national agenda.
Stands B2 & B3
The ARC Foundation is a French Foundation 100% dedicated to cancer research. With excellence and innovation at the core of its scientific policy, it selects and supports each year the most promising projects, from basic to clinical research, with one goal: improving prevention, screening, diagnosis, treatments and quality of life for all cancer patients. The ARC Foundation also aims to share knowledge and advances in oncology by editing many publications to help the general public and professionals to fight cancer more efficiently. Each year, the ARC Foundation devotes nearly €30 million to these missions. Without the support of public subsidies, its actions rely solely on the generosity of its donors and testators.
The foundation is dedicated to the primary prevention of cancer based on educating young people. The foundation develops its work in the region "Ile de France Essone" with various partners: schools, parents associations, health and social structures, and LNCC-91 ( Ligue nationale contre le cancer from Essone). The major activities of the foundation encompass 3 strategic axes:
- Organizing territorial network of preventive interventions with all the partners of the territory involved in such an orientation. We develop coherent and evidence based educative pathways all over the educative periods and evaluate their efficacy in increasing knowledge and changing at risk behaviours.
- Supporting and performing intervention research to develop new types of pedagogic intervention in school with education and health professionals.
- Creating teaching sessions locally adapted to partners and also university training for students with the "Paris-Sud" university and brain storming sessions on preventive activities. We also organized communication events in relation with the international events ( tobaco day, addiction week, physical exercice, sun...).
The Fraunhofer Institute for Ceramic Technologies and Systems IKTS conducts applications-oriented research in the field of high-performance ceramics. The three branches of the institute form the largest institution for ceramics research in Europe. With its comprehensive know-how in the fields of materials science, manufacturing technology, systems integration and materials and process analysis, Fraunhofer IKTS combines different technology worlds. At its heart are market-viable ceramic solutions for mechanical and automotive engineering, energy and environmental technology, optics, bio- and medical technology as well as electronics and microsystems technology.
GY Highland Biotech LLC is centered on the development of new technology related to cancer detection. We aspire to contribute to women’s and newborn health in addition to cancer prevention & detection by serving the needs of healthcare professionals in OBGYN, Neonatology, Clinical Laboratory, and Pathology.
Currently, we are promoting our innovative cervical cancer detecting technique, Folate Receptor Medicated Staining Solution (FRD), for the early detection of CIN2+. Results are determined immediately (60 seconds). Meta-analysis has revealed that the FRD has a sensitivity and specificity of 85% for detecting CIN2+.
Harmonic Pharma is the very first company developing and applying the polypharmacology paradigm to strategic therapeutic areas such as oncology. The company’s know-how derives from a breakthrough innovation allowing to revisit safe drugs and drug candidates.
Hundreds regional Hospital Liaison Committees in the Central Europe area maintain contact with clinicians of all specialties so that Jehovah’s Witness patients can obtain non-blood medical care.
Hospital Information Services coordinates this activity. By means of presentations and personal discussions we inform about our ethical position and provide practice-oriented expert information on blood conservation strategies without cost.
Stands 12 & 13
A Cancer Information Service (CIS) offers information about cancer and support services to cancer patients, their family and friends, the public, and health care professionals. A CIS provides a one-on-one interaction with users that is free and confidential.
As the leading not-for-profit supplier of health products, IDA Foundation’s mission is to improve access to and deliver high-quality essential medicines and medical supplies at the lowest possible price to low- and middle-income countries (LMIs). We distribute over 3000 different medicines and medical supplies to customers in over 130 countries. As part of its mission, IDA Foundation aims to improve access to essential oncology medicines, by building stock of high priority products for treatment of the most common forms of cancer. This brings treatment and palliative care within reach for many more patients, by making it more affordable and accessible.
Institut Curie, a major player in the fight against cancer, is a private foundation granted charitable status accepting public donations and legacy gifts. Based is the Paris area (Paris, Orsay, Saint-Cloud), it comprises an internationally renowned cancer research center and a leading-edge hospital group, a pioneer in precision medicine that cares for patients diagnosed with all types of cancer including rare ones. Institut Curie was founded in 1909 on a model devised by Marie Curie, twice winner of the Nobel Prize, and still at the cutting edge: "from fundamental research to innovative treatments". Its 3,300 staff are all devoted to the institute’s missions that include treatment and research for the benefit of cancer patients, training and education as well as conservation of scientific heritage. In 2011 Institut Curie became a founding member of PSL Research University Paris.
Stands 12 & 13
The French National Cancer Institute is a health and science agency dedicated to cancer. Placed under the umbrella of the Ministries of Health and Research, it brings together all of the players involved in the fight against cancer in France, to enable a long-lasting, coordinated national policy against cancer. It operates on an interdisciplinary basis, with the aim of federating, uniting and mobilising players and resources around joint projects. The Institute is a public expertise agency (produces or co produces regulatory documents) whose means of actions are the implementation of partnerships with and through the existing public and/or private structures of Care, Public Health and Research, and calls for proposals. The Institute covers the whole spectrum of the fight against cancer and has four main areas of interventions:
- Public Health: Implement a better cancer prevention strategy and diagnose cancer earlier
- Care: Guarantee access to top-quality care for all, in line with the principle of equity
- Research: Make innovation and progress more accessible
- Public information: Bring the means to participate in the fight against cancer to everyone (general public, patients, health care professionals)
The Institute's aspiration is to help lower mortality due to cancer and improve the quality of living for people with cancer. The Institute has been a full UICC member since 2006.
The mission of Instituto Nacional de Cancerología is to develop health care, teaching and research excellence in oncology in Mexico. It aims to achieve this by being leaders in the generation of strategies for controlling cancer and reducing its impact as a public health problem in Mexico. In 1962, Instituto Nacional de Cancerología was accepted as full UICC member.
The International Agency for Research on Cancer (IARC) is the specialized cancer agency of the World Health Organization. It concludes in 2016 a one-year series of jubilee celebrations.
The objective of IARC is to promote international collaboration in cancer research. Its interdisciplinary approach brings together skills in epidemiology, laboratory sciences and biostatistics allowing to identify the causes of cancer so that preventive measures may be adopted and the burden of disease alleviated. One salient feature of IARC is its expertise in coordinating research across boundaries and organizations, with a particular focus on low- and middle-income countries.
The IAEA established PACT to respond to the growing global cancer crisis. In partnership with the World Health Organization and others, PACT supports IAEA Member States to expand access to health technologies, build skills and mobilize resources to develop a complete range of quality, effective and sustainable cancer services.
Stand 3, 4, 5 & 6 (Stands shared with ALIAM)
The French League against cancer is a NGO that aims towards 4 major objectives: inform on cancer risk factors, fund research against cancer, support patients and their relatives, advocate for better health policies. The association federates 103 local committees, 13 000 volunteers, 640 000 subscribers and 450 employees.
The Love Hope Strength Foundation is an international, music-centric cancer charity dedicated to providing support for cancer centers, and inspiration to those affected, throughout the world. The mission is to save lives, right now, with the advances that have already been made in cancer care. We do not fund cancer research, rather we use our funds to purchase medical equipment and supplies, raise awareness through special events, documentaries and media, build cancer centers and find bone marrow donors.
Macmillan Cancer Support is the UK’s leading cancer care charity. We provide support to patients, carers, family and friends, from diagnosis, through treatment and beyond. Our range of services helps people at a difficult time, so they can start to take back control of their lives. We also make change happen; listening to people affected by cancer and working with high-profile organisations and policy makers to improve cancer care across the UK. All our campaigns have one common goal – to make a positive and permanent change to the lives of people affected by cancer.
The McCabe Centre for Law and Cancer is a joint initiative of Cancer Council Victoria and the Union for International Cancer Control. Its mission is to contribute to the effective use of the law for cancer prevention, treatment, supportive care and research.
The McCabe Centre:
- conducts research, policy development and training
- develops and disseminates materials on the relationship between law and cancer control
- provides cancer control organizations and others with an interest in cancer control with a place (both real and virtual) to go for information
- provides a forum for discussion and sharing of information and experiences
- connects lawyers, legal academics and law students with cancer control researchers and with other disciplines
The McCabe Centre collaborates with other non-governmental organizations, law schools and legal practitioners, and works, as appropriate, with governments and intergovernmental organizations.
The McCabe Centre is the only centre of its kind in the world. It aims to help build capacity globally in the effective use of law for cancer control, working with member organizations of UICC, the leading global cancer control non-governmental organization, with over 760 member organisations across 155 countries.
The McCabe Centre’s current areas of focus are the key cancer prevention areas of tobacco and alcohol control and obesity prevention, access to medicines, and cancer treatment and supportive care. Its work spans diverse areas of domestic and international law including health law, consumer protection law, constitutional law, trade law, investment law, intellectual property law, drug control law and human rights law.
Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME.
With two decades of experience, Mercurius health is a know-how transfer company whose core business is Radiotherapy, Nuclear Medicine and Radiopharmaceutical Production.
We integrate specialized dedicated multidisciplinary teams of Medical Physicists, Dosimetrists, Technologists and Physicians able to fully operate your center, to fulfill a specific need and/or to train your own teams, providing a wide range of services:
- Onsite training
- New Projects and Startup Support
- Independent acceptance and commissioning of accelerators and related equipment
- Operational management
- Independent consultancy and Remote Support including Treatment Planning
Mercurius Health believes his know-how is an asset and can contribute to the success of Cancer Treatment Projects under implementation or wishing to move a step forward.
Stands 41 & 42
The National Cancer Institute (NCI) is a component of the National Institutes of Health (NIH), one of eight agencies that compose the Public Health Service (PHS) in the Department of Health and Human Services (DHHS). The National Cancer Institute is the United States of America Federal Government’s agency for cancer research and training. We are responsible for the dissemination of cancer and cancer-related information to the public as well as assessing the incorporation of state-of-the-art cancer treatments into clinical practice. Our audience includes patients, researchers, and health care professionals nation-wide. Our resources cover topics that include patient education, grant resources, fellowship opportunities, internship information, and other cancer-related programs in respect to the cause, diagnosis, prevention and treatment of cancer. Visit http://www.cancer.gov for more information.
The National Cancer Registrars Association (NCRA) is a non-profit organization that represents more than 5,800 cancer registry professionals and Certified Tumor Registrars. The mission of NCRA is to promote education, credentialing, and advocacy for cancer registry professionals. Cancer registrars are data information specialists that capture a complete history, diagnosis, treatment, and health status for every cancer patient in the U.S. The data provide essential information to researchers, healthcare providers, and public health officials to better monitor and advance cancer treatments, conduct research, and improve cancer prevention and screening programs. NCRA promotes standardization in the collection and use of cancer data through the Certified Tumor Registrar (CTR) credential.
Stands 28 & 29
The National Cancer Society Malaysia (NCSM) is the first cancer not-for-profit, tax exempt organisation in Malaysia, established in 1966. It is the only one that provides an extensive range of cancer screening services and support to people affected by cancer.
Financed entirely by voluntary contributions from the public, NCSM supports patients and caregivers through their cancer journey via its four centres - Resource & Wellness Centre, Cancer & Health Screening Clinic, Nuclear Medicine Centre, Children’s Home of Hope and Smoking Cessation Clinic.
Backed by its philosophy to “Educate, Care and Support”, NCSM aims to:
- Educate - To decrease the incidence of cancer in Malaysia by raising public awareness on prevention, screening and early detection of cancer through education.
- Care – To raise accessibility of cancer services in Malaysia by providing advanced facilities in screening and diagnosis of cancer.
- Support – To empower individuals and those affected with cancer to maintain the highest possible quality of life.
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world's leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.
The NCD Alliance unites over 2,000 civil society organisations combating non-communicable diseases (NCDs), including cancer, cardiovascular disease, chronic respiratory diseases, diabetes, and mental health and neurological disorders. We are proud to count the UICC as one of our founding Steering Group Federations. The NCD Alliance’s four strategic pillars are based on advocacy, accountability, capacity building and knowledge exchange, and we will be available in the global village to discuss these areas further. Following the adoption of Agenda 2030, we are working on translating global policy into national action and would be delighted to exchange experiences on this.
The North American Association of Central Cancer Registries, Inc. (NAACCR) is a professional organization that develops and promotes uniform data standards for cancer registration; provides education and training; certifies population-based registries; aggregates and publishes data from central cancer registries; and promotes the use of cancer surveillance data and systems for cancer control and epidemiologic research, public health programs, and patient care to reduce the burden of cancer in North America.
The Norwegian Cancer Society (NCS) is a nation-wide, non-profit voluntary organisation. Our activities are funded by donations and fundraising, bequests and support from Norsk Tipping [state owned gaming company]. Several hundred thousand donaors and members, as well as corporate sponsors, support the Society’s work. This broad support makes us the leading cancer NGO in Norway and contributes to a focused effort in the area of research funding, cancer care, cancer prevention, information and international collaboration. Our main objectives are to:
- Contribute to ensure that fewer people develop cancer (reduction of the prevalence and incidence of cancer)
- Contribute to more people surviving cancer
- Ensure the best quality of life for people affected by cancer (cancer patients and their relatives)
NCS also cooperates with and funds twelve voluntary patients’ associations nationwide. They provide patient care, recreation and information services to their members and play a key role in influencing local authorities and health personnel.
To develop tools and to work to influencing positive policy changes in regards to the holistic management of cancers in Oman in order to achieve our vision.
1. Advocate and create Awareness for all cancers Nationwide.
2. Patient Empowerment of patients and their families.
3. Education and training.
5. Develop Political Will for Cancers.
6. Fund Raising.
Regular Repeated Self Examination Leads to Early Diagnosis And Possibility of Excellent Prognosis and Cure.
To strengthen the patients’ voice, we are pleased to announce the creation of the Patient Group Pavilion in the Global Village.
The Patient Group Pavilion is exclusively dedicated to patient advocates and support groups, and aims to promote cross-sector collaboration, exchanges of best practice and patient advocacy both at global and national levels.
A schedule of daily discussions will feature successful advocacy initiatives undertaken by active patient support groups.
A panel of international experts will select the best “Advocacy and Policy Reports” submitted by patient groups as part of the online call for abstracts, so they can be presented in the dedicated pavilion.
More information here
Pfizer Oncology is proud to be a sponsor of the 2016 World Cancer Congress, the premier forum to unite diverse members of the global cancer community and develop substantial collaborations to drive change for patients globally. This year’s theme, Mobilising Action – Inspiring Change, is one that Pfizer embraces as we strive to redefine life with cancer.
South Africa’s best-loved Breast Cancer Community Carer, PinkDrive is the indispensable, tangible breast cancer Public Benefit Organisation (PBO) powering South Africa’s first mobile PinkDrive Mammography Unit and PinkDrive Educational Unit through our country, driving home the fact that ‘Early Detection Saves Lives’. PinkDrive currently runs two “Pink” mobile breast check units, as well as three educational cars. Both units travel to semi-urban and urban areas around South Africa with the aim of enabling various disadvantaged communities access to education, physical examinations and how to do breast self-examination. The mobile screening unit successfully launched in the Western Cape in 2011 and operated through local clinics, community health centres and hospitals. The unit returned to Gauteng in December 2012, and has continued working through local clinics, community health centres and hospitals in Gauteng.
At Qweety, our mission is to design, develop and operate innovative technologies in Public Health for prevention of addictions and health promotion.
Qweety is a mobile application offering a disruptive way to support smokers in quitting their addiction: instead of looking for hypothetical long-term health benefit, it creates a short-term funny social game and interactions with their friends and family, including non-smokers. Quitting effort is rewarded by incentive, bet by relations, or offered by sponsors.
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. It is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century.
A non-profit organization founded in February 2013 by an eminent Medical Oncologist in dedication to her elder brother who died of pancreatic cancer. Although led by medical doctors, members include nurses, family members of cancer patients, cancer survivors and volunteers from general public. Our mission is “To enhance awareness on prevention and early detection of cancer”.
Activities are carried out by 8 working teams: Health Education; Health Screening; Treatment Support – especially those in need who are diagnosed with potentially curable cancer at an early stage; Research and Training; Public Relations and Information; Foreign Relations; Supporting Cancer Survivors and Fund Raising.
The Lancet Oncology, a specialty journal published by The Lancet, is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global oncology policy, and inform constructive change worldwide. With comprehensive coverage, the journal publishes only the highest quality original research and opinion with relevance to clinical decision making and cancer health systems.
Founded in 1947, TACRC is the first non-governmental cancer organization in Turkey. Many of the earliest works in cancer control started by TACRC are: the First Cancer Hospital (1962), Turkish Journal of Cancer (1973), National Cancer Congress (1975), Cancer Mortality Statistics (1983), World Cancer Day (2005), Cancer Patient Forum (2006) and others. TACRC was awarded as the best cancer society by UICC (2008). It focuses on Cancer Control, Prevention, Research, Tobacco Control, Advocacy, Patient Groups, Public and Professional Education, Awareness Campaigns, Meetings, Patient Conferences and International Relations.
Stands 10 & 11
UNICANCER unites all of the Cancer Centres in France: these private non-profit health institutions are exclusively devoted to healthcare, research and education and training in oncology.
Its mission is to enable Cancer Centers to stay ahead and innovate together, and always for the benefit of their patients.
UNICANCER guarantees in all of the Group’s establishments:
- The same quality of care
- Fast and safe access to innovations
- Care coverage accessible for everyone without overrunning of fees
- The possibility of participating in clinical trials
Stands 45, 46 & 47
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs over 7,000 people, located at manufacturing sites, sales and support offices worldwide.
It’s the knowledge age – and it’s Wiley’s customers who lead the world’s knowledge economy.
Our customers drive progress by providing quality education, the right skills to fulfil global demand and scientific research to fuel innovation. Our customers care, their organizations succeed and the world benefits.
Wiley develops digital education, learning, assessment and certification to help universities, businesses and individuals bridge between education and employment and achieve their ambitions.
We partner with learned societies and support researchers to communicate discoveries that make a difference. Our digital content, books and 1600 online journals build on a 200 year heritage of quality publishing.
Wisepress.com, Europe’s leading conference bookseller, has a range of books and journals relevant to the themes of the meeting. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers. Follow us on Twitter for the latest news @WisepressBooks.
World Cancer Research Fund International leads and unifies a network of cancer prevention charities with a global reach. We champion the latest and most authoritative scientific research from around the world on cancer prevention and survival through diet, weight and physical activity, so that we can help people make informed lifestyle choices to reduce their cancer risk. We provide essential advice and guidance to help policymakers develop effective policies to reduce the cases of preventable cancer and other non-communicable diseases.
Our goal is to build a better, healthier future for people all over the world. Working through offices in more than 150 countries, WHO staff work side by side with governments and other partners to ensure the highest attainable level of health for all people.
Together we strive to combat diseases – infectious diseases like influenza and HIV and noncommunicable ones like cancer and heart disease. We help mothers and children survive and thrive so they can look forward to a healthy old age. We ensure the safety of the air people breathe, the food they eat, the water they drink – and the medicines and vaccines they need.
Zahra Breast Cancer Association is a nonprofit organization established in 2007. Headquartered in Riyadh, in the Kingdom of Saudi Arabia, the Zahra Breast Cancer Assocation aims to raise awareness of breast cancer and prevention methods and to clarify the extent of the disease in the Kingdom. Main objectives include implementing awareness programs and comprehensive survey programs around the kingdom, directing patients to the concerned authorities to receive services which are dedicated for them and developing the Saudi capabilities in the researches related to Breast Cancer aligned with training, and educational programs.